Navigation Links
The legacy of BIO 2006, what it will be and how we need to plan for it now

An interesting meeting took place this past week at the University of Chicagos Gleacher Center hosted by the Chicago Technology Forum. The focus of the meeting was an opportunity to hear from four individuals, who have been intimately involved in the last annual BIO meetings in different cities, as a preview to what we might expect or should prepare for when this Oly......

Full article >>> ith this meeting was to get this Chicago/Midwest audience, a mlange of bio-businessmen, students, city/state government officials, and university administrators (as well as what Chicago produces in great quantities: lawyers!), to tune in now to what Chicago and the Midwest really want to get out of this event. In other words, using the jargon of the meeting, what will be our legacy?

Rosen......

Full article >>> ssence, all of Canada)

By now, Ray Briscuso knows the Midwest well! Four to five years ago, a contingent from Chicago went to Washington to convince him and the BIO leadership why they needed to consider Chicago as a site for a future BIO annual event. BIO knew that Chicago was a great convention town but was it really a BIO town; had the industry sufficiently matured to make this an exci......

Full article >>> ology in your state/region, stimulus of growth of biotech companies and activities in the region.

Putting your bid in immediately after the meeting has concluded for a shot at another meeting (the lead time has increased for selection of sites from3-4 years to about7-8 years), so as to ensure follow-up umbrella effect of BIO on further galvanizing all of the above

Getting the l......

Full article >>> ties in the past, because the event is not about the convention but about proximity to great research and great biotech companies (fortunately Chicago met all three conditions); hence you will not see BIO meetings in Orlando and Disneyworld.

The greatest tangible benefits to a city and region would be the national and global spotlight on that city and the impact of that spotlight on deal ......

Full article >>> s been syndicated on the Wisconsin Technology Network courtesy of ePrairie, a user-driven business and technology news community distributed via the Web, the wireless Web and free daily e-mail newsletters.

The opinions expressed herein or statements made in the above column are solely those of the author and do not necessarily reflect t......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 12/12/05


Related biology technology :

1. Thompsons HHS legacy will include efforts to combat disease in Africa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2017)... , Feb. 22, 2017 Origin (Origin Agritech, LLC, a ... and seed provider, and Arcadia (Arcadia Biosciences, ... develops and commercializes agricultural productivity traits and nutritional products, today announced ... biotechnology product developed in China to ... trials. ...
(Date:2/22/2017)... PHOENIX and SAN DIEGO ... Technology Holdings (the "Company") (OTCQB:CELZ) announced today expansion ... universal donor stem cell product through establishment of ... initiated research activities at the San Diego BioLabs ... Companies, Boehringer Ingelheim, Novartis, and Sanofi. ...
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... healthcare organizations to build connected digital health applications, announced a partnership with Redox, ... users to seamlessly connect to many clinical systems while keeping data secure in ...
(Date:2/21/2017)... , ... February 21, 2017 , ... The medical potential ... their use, in multiple areas of medicine, due to their differentiating characteristics. Stem cells ... they have the ability to be induced to become tissue or organic-specific cells with ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
(Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... fastest growing genetic information companies, today announced that it ... results and provide 2017 guidance on Monday, February 13, ... call that day at 4:45 p.m. Eastern / 1:45 ... management team will briefly review financial results, guidance, and ...
Breaking Biology News(10 mins):